Form 4: Sanofi Insider Buys Shares
Insider Transaction (Form 4)
Sanofi, a 10% owner of Sanofi, purchased 300,000 shares of common stock on August 6, 2026 for $17.00 per share.
Summary
- Conversion of derivative: acquired 782,855 Common Stock on August 6, 2026; holds 782,855 after (Indirect).
- Open-market purchase: acquired 300,000 Common Stock at $17.00 ($5,100,000) on August 6, 2026; holds 1,082,855 after (Indirect).
- Conversion of derivative: disposed of 782,855 Series C Preferred Stock on August 6, 2026 (Indirect).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $5,100,000, committing personal capital to the stock.
Insider Transactions
Sanofi — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-06 | Conversion of derivative | Common Stock | 782,855 | — | — | 782,855 |
| 2026-08-06 | Open-market purchase | Common Stock | 300,000 | $17 | $5.1M | 1,082,855 |
| 2026-08-06 | Conversion of derivative | Series C Preferred Stock | 782,855 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-06 | Conversion of derivative (782,855 shares) |
| 2026-08-06 | Open-market purchase (300,000 shares) |
| 2026-08-06 | Conversion of derivative (782,855 shares) |
Keywords
insider transaction, Form 4, ATTO, Attovia Therapeutics, Inc., bullish, Sanofi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.